A recent study of a cohort of 525 AML patients treated with intensive chemotherapy showed that a higher ferritin level was significantly associated with age, higher CRP levels, leukocytosis, FAB M4/M5 subtypes, NPM1, and FLT3-ITD mutations (18). Here, FLT3 is linked to acute myeloid leukemia.